BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 6038874)

  • 1. Effect of SK&F-12185 [dl-2(p-aminophenyl)-2-phenylethylamine] on adrenocortical function in primary aldosteronism.
    Gabrilove JL; Nicolis GL; Gallagher TF
    J Clin Endocrinol Metab; 1967 Sep; 27(9):1337-40. PubMed ID: 6038874
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of d-2(p-aminophenyl)-2-phenylethylamine (SK&F-12185) in Cushing's syndrome associated with adrenocortical carcinoma.
    Gabrilove JL; Nicolis GL; Gallagher TF
    Metabolism; 1968 Oct; 17(10):936-42. PubMed ID: 4877990
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of DL-2(p-aminophenyl)-2-phenylethylamine on adrenocortical function in Cushing's syndrome due to nontumorous adrenocrotical hyperfunction.
    Gabrilove JL; Nicolis GL; Gallagher TF
    J Clin Endocrinol Metab; 1967 Nov; 27(11):1550-7. PubMed ID: 6075585
    [No Abstract]   [Full Text] [Related]  

  • 4. [On regulation of the daily rhythm of adrenal cortex hormones in corticosteroma].
    Gur'eva IG; Kertsman VI
    Probl Endokrinol Gormonoter; 1966; 12(4):3-7. PubMed ID: 4301286
    [No Abstract]   [Full Text] [Related]  

  • 5. [Kidney blood supply and functional state of the adrenal cortex in patients with hypertensive disease].
    Mikhaĭlin SE
    Vrach Delo; 1971 Jun; (6):4-6. PubMed ID: 5093594
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of aminoglutethimide upon adrenal function and cortisol metabolism in Cushing's syndrome.
    Schteingart DE; Conn JW
    J Clin Endocrinol Metab; 1967 Dec; 27(12):1657-66. PubMed ID: 6060954
    [No Abstract]   [Full Text] [Related]  

  • 7. Bilateral adrenal hyperplasia as a cause of primary aldosteronism with hypertension, hypokalemia and suppressed renin activity.
    Davis WW; Newsome HH; Wright LD; Hammond WG; Easton J; Bartter FC
    Am J Med; 1967 Apr; 42(4):642-7. PubMed ID: 6024721
    [No Abstract]   [Full Text] [Related]  

  • 8. [Attempted experimental chronic block of adrenal cortex hormone synthesis during growth].
    Sendrail M; Gleizes L; Sendrail-Pesqué M; Chkili T; Fabre MT; Vassal D
    Pathol Biol (Paris); 1969 Nov; 17(21):939-51. PubMed ID: 4907649
    [No Abstract]   [Full Text] [Related]  

  • 9. Investigations on the adrenocortical function of normal and obese dogs.
    Rijnberk A; Kinderen PJ der
    Acta Physiol Pharmacol Neerl; 1967 Dec; 14(4):521. PubMed ID: 5582725
    [No Abstract]   [Full Text] [Related]  

  • 10. Non-tumorous "primary" aldosteronism: II. Type not relieved by glucocorticoid.
    Salti IS; Ruse JL; Stiefel M; Delarue NC; Laidlaw JC
    Can Med Assoc J; 1969 Jul; 101(1):11-6. PubMed ID: 5793350
    [No Abstract]   [Full Text] [Related]  

  • 11. Hereditary adrenocortical unresponsiveness to adrenocorticotropic hormone.
    Kelch RP; Kaplan SL; Biglieri EG; Daniels GH; Epstein CJ; Grumbach MM
    J Pediatr; 1972 Oct; 81(4):726-36. PubMed ID: 4342294
    [No Abstract]   [Full Text] [Related]  

  • 12. [Day-night secretory rhythms of adrenocortical steroids in kidney disease patients with nycturia].
    Hohenegger M
    Endokrinologie; 1966 Dec; 50(5):260-6. PubMed ID: 5989928
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of metyrapone on aldosterone secretion in man.
    Tucci JR; Espiner EA; Jagger PI; Lauler DP
    Acta Endocrinol (Copenh); 1967 Nov; 56(3):376-84. PubMed ID: 4293345
    [No Abstract]   [Full Text] [Related]  

  • 14. Adrenocortical responses during tularemia in human subjects.
    Beisel WR; Bruton J; Anderson KD; Sawyer WD
    J Clin Endocrinol Metab; 1967 Jan; 27(1):61-9. PubMed ID: 4225306
    [No Abstract]   [Full Text] [Related]  

  • 15. [Some findings on the androgen functions of the adrenal cortex in female obesity].
    Ferramosca B; Bacci G; Frizziero L; Masiello O
    Endocrinol Sci Cost; 1967 Nov; 29(5):323-43. PubMed ID: 4892898
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of an adrenal 11-beta, 17-alpha hydroxylase inhibitor in juvenile-onset diabetes mellitus.
    Narduzzi JV; Sabeh G; Weir TF; Cleary WJ; Danowski TS
    Clin Pharmacol Ther; 1967; 8(5):684-91. PubMed ID: 4293304
    [No Abstract]   [Full Text] [Related]  

  • 17. [Corticosteroidogenesis inhibitors. II. A new cortico-adrenal inhibitor: amino-glutethimide (16,038Ba)].
    Philbert M; Luton JP; Mathieu de Fossey B; Bricaire H
    Presse Med (1893); 1968 May; 76(23):1107-10. PubMed ID: 5657304
    [No Abstract]   [Full Text] [Related]  

  • 18. [Repercussion of corticotherapy on the hypothalamo-pituitary-adrenal axis function].
    Bloch-Michel H; Gorins A; Thevenet M
    Presse Med (1893); 1970 Mar; 78(13):599-601. PubMed ID: 4314719
    [No Abstract]   [Full Text] [Related]  

  • 19. Changes in adrenocortisol function of patients with gonadal dysgenesis after treatment with estrogen.
    Sobrinho LG; Kase NG; Grunt JA
    J Clin Endocrinol Metab; 1971 Jul; 33(1):110-4. PubMed ID: 4934139
    [No Abstract]   [Full Text] [Related]  

  • 20. [The effect of specific treatment on the adrenal cortex function in patients with syphilis].
    Shteĭn AA; Dubovyĭ MI; Shcherbakova AK
    Vestn Dermatol Venerol; 1968 Aug; 42(8):58-61. PubMed ID: 5741103
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.